Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Calderon

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Allergy|November 8, 2014
Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individualsM H Shamji, V Bellido, G W Scadding, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|May 19, 2012
Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statementM A Calderon, R Gerth van Wijk, I Eichler, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
Allergy|February 3, 2017
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position PaperM H Shamji, J H Kappen, M Akdis, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Allergy|January 26, 2017
Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysisS Dhami, H Zaman, E-M Varga, et al.
Allergy|January 26, 2017
Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position PaperO Pfaar, M A Calderon, C P Andrews, et al.
Allergy|September 24, 2017
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitisG Roberts, O Pfaar, C A Akdis, et al.
Clinical and Translational Allergy|November 30, 2016
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration projectM A Calderon, P Demoly, T Casale, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Allergy|November 8, 2014
Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individualsM H Shamji, V Bellido, G W Scadding, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|May 19, 2012
Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statementM A Calderon, R Gerth van Wijk, I Eichler, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
Allergy|February 3, 2017
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position PaperM H Shamji, J H Kappen, M Akdis, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Allergy|January 26, 2017
Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysisS Dhami, H Zaman, E-M Varga, et al.
Allergy|January 26, 2017
Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position PaperO Pfaar, M A Calderon, C P Andrews, et al.
Allergy|September 24, 2017
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitisG Roberts, O Pfaar, C A Akdis, et al.
Clinical and Translational Allergy|November 30, 2016
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration projectM A Calderon, P Demoly, T Casale, et al.
Pageof 4